{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T18:53:29Z","timestamp":1769108009921,"version":"3.49.0"},"reference-count":16,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"30","license":[{"start":{"date-parts":[[2023,7,28]],"date-time":"2023-07-28T00:00:00Z","timestamp":1690502400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,7,28]]},"abstract":"<jats:sec>\n            <jats:title>Rationale:<\/jats:title>\n            <jats:p>Acute myeloid leukemia (AML)\/myeloid sarcoma (MS) is risk-stratified based on cytogenetics. Although most congenital AML\/MS have a dismal prognosis, certain genetic variants such as t (8, 16) [<jats:italic toggle=\"yes\">KAT6A::<\/jats:italic>cAMP response element-binding protein (CREB) - binding protein fusion] and more recently t (8, 22) [<jats:italic toggle=\"yes\">KAT6A::EP300<\/jats:italic> fusion] have shown spontaneous remissions. <jats:italic toggle=\"yes\">KAT6A<\/jats:italic> located on chromosome 8p11 encodes KAT6A protein, a histone\/lysine acetyltransferase enzyme. Numerous partner genes associated with <jats:italic toggle=\"yes\">KAT6A<\/jats:italic> include cAMP response element-binding protein (CREB) - binding protein (16p13), <jats:italic toggle=\"yes\">EP300<\/jats:italic> (22q13), <jats:italic toggle=\"yes\">LEUTX<\/jats:italic> (9q13), <jats:italic toggle=\"yes\">NCOA2, NCOA3<\/jats:italic>, and <jats:italic toggle=\"yes\">ASXL2<\/jats:italic>.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Patient concerns:<\/jats:title>\n            <jats:p>In this article, we describe an otherwise healthy infant who presented with skin nodules on the face and scalp without any systemic or CNS involvement. A biopsy of the cutaneous lesion was consistent with congenital MS.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Diagnoses:<\/jats:title>\n            <jats:p>Through molecular testing, we found that our patient had the <jats:italic toggle=\"yes\">KAT6A::EP300<\/jats:italic> mutation. This is one of the rare recurrent cytogenetic abnormalities that are linked to congenital AML.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Intervention:<\/jats:title>\n            <jats:p>Our patient underwent spontaneous remission with watchful waiting.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Outcome:<\/jats:title>\n            <jats:p>Our patient has remained in spontaneous remission for 24 months.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Lessons:<\/jats:title>\n            <jats:p>Even though the <jats:italic toggle=\"yes\">KAT6A::EP300<\/jats:italic> mutation in adults is a poor prognostic marker, a similar mutation in congenital AML has a higher likelihood of spontaneous remission. Hence, conservative management might be an initial management strategy for clinically stable patients.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000034258","type":"journal-article","created":{"date-parts":[[2023,10,6]],"date-time":"2023-10-06T22:18:43Z","timestamp":1696630723000},"page":"e34258","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":4,"title":["KAT6A::EP300 fusion in congenital myeloid sarcoma: Yet another novel molecular marker indicating spontaneous remission?: A case report"],"prefix":"10.1097","volume":"102","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5374-5888","authenticated-orcid":false,"given":"Smitha","family":"Hosahalli Vasanna","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Division of Pediatric Hematology-Oncology, University Hospitals-Rainbow Babies and Children\u2019s Hospital, Cleveland Medical Center, Cleveland, OH"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sonal D.","family":"Shah","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University Hospitals Cleveland Medical Center, Cleveland, OH"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bethany R.","family":"Rohr","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University Hospitals Cleveland Medical Center, Cleveland, OH"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Breanne","family":"Roche","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Division of Pediatric Hematology-Oncology, University Hospitals-Rainbow Babies and Children\u2019s Hospital, Cleveland Medical Center, Cleveland, OH"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Howard","family":"Meyerson","sequence":"additional","affiliation":[{"name":"Department of Pathology, University Hospitals Cleveland Medical Center, Cleveland, OH."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irina","family":"Pateva","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Division of Pediatric Hematology-Oncology, University Hospitals-Rainbow Babies and Children\u2019s Hospital, Cleveland Medical Center, Cleveland, OH"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"e26450","DOI":"10.1002\/pbc.26450","article-title":"FISH identifies a KAT6A\/CREBBP fusion caused by a cryptic insertional t (8;16) in a case of spontaneously remitting congenital acute myeloid leukemia with a normal karyotype.","volume":"64","author":"Barrett","year":"2017","journal-title":"Pediatr Blood Cancer"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1002\/pbc.22859","article-title":"Spontaneous remission of congenital acute myeloid leukemia with t (8;16) (p11;13).","volume":"56","author":"Wu","year":"2011","journal-title":"Pediatr Blood Cancer"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1080\/10428194.2018.1434885","article-title":"Deep spontaneous molecular remission in a patient with congenital acute myeloid leukemia expressing a novel MOZ-p300 fusion transcript.","volume":"59","author":"Ikawa","year":"2018","journal-title":"Leuk Lymphoma"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1111\/j.1365-2230.2005.02022.x","article-title":"Spectrum of clinical presentation, treatment and prognosis in a series of eight patients with leukaemia cutis.","volume":"31","author":"Watson","year":"2006","journal-title":"Clin Exp Dermatol"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1309\/WYACYWF6NGM3WBRT","article-title":"Leukemia cutis.","volume":"129","author":"Cho-Vega","year":"2008","journal-title":"Am J Clin Pathol"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"777","DOI":"10.3390\/cancers13040777","article-title":"Infant acute myeloid leukemia: a unique clinical and biological entity.","volume":"13","author":"Calvo","year":"2021","journal-title":"Cancers (Basel)"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1046\/j.1365-2141.2002.03459.x","article-title":"Congenital leukaemia: the Dutch experience and review of the literature.","volume":"117","author":"Bresters","year":"2002","journal-title":"Br J Haematol"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1080\/10428194.2020.1845335","article-title":"Congenital acute myeloid leukemia: challenges and lessons. A 15-year experience from the UK.","volume":"62","author":"Green","year":"2021","journal-title":"Leuk Lymphoma"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0959-437X(99)80027-6","article-title":"Modifying chromatin and concepts of cancer.","volume":"9","author":"Jacobson","year":"1999","journal-title":"Curr Opin Genet Dev"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"7184","DOI":"10.1093\/emboj\/20.24.7184","article-title":"Activation of AML1-mediated transcription by MOZ and inhibition by the MOZ-CBP fusion protein.","volume":"20","author":"Kitabayashi","year":"2001","journal-title":"EMBO J"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"5019","DOI":"10.1038\/onc.2010.254","article-title":"Crosstalk between leukemia-associated proteins MOZ and MLL regulates HOX gene expression in human cord blood CD34+ cells.","volume":"29","author":"Paggetti","year":"2010","journal-title":"Oncogene"},{"issue":"Supplement 1","key":"R13-20250504","doi-asserted-by":"crossref","first-page":"3451","DOI":"10.1182\/blood-2021-154052","article-title":"CREBBP alterations are associated with a poor prognosis in De Novo AML.","volume":"138","author":"Lamble","year":"2021","journal-title":"Blood"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"2704","DOI":"10.1182\/blood-2013-02-485524","article-title":"Pediatric acute myeloid leukemia with t (8;16) (p11; p13), a distinct clinical and biological entity: a collaborative study by the International-Berlin-Frankfurt-M\u00fcnster AML-study group.","volume":"122","author":"Coenen","year":"2013","journal-title":"Blood"},{"key":"R16-20250504","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1093\/emboj\/20.6.1331","article-title":"p300\/CBP-mediated p53 acetylation is commonly induced by p53-activating agents and inhibited by MDM2.","volume":"20","author":"Ito","year":"2001","journal-title":"EMBO J"},{"key":"R20-20250504","doi-asserted-by":"crossref","first-page":"e28663","DOI":"10.1002\/pbc.28663","article-title":"Rapidly progressing acute myeloid leukemia with KAT6A-LEUTX fusion in a newborn.","volume":"67","author":"Sramkova","year":"2020","journal-title":"Pediatr Blood Cancer"},{"key":"R21-20250504","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/0165-4608(92)90013-X","article-title":"Acute monocytic leukemia with (8; 22) (p11; q13) translocation. Involvement of 8p11 as in classical t(8; 16) (p11; p13).","volume":"60","author":"Lai","year":"1992","journal-title":"Cancer Genet Cytogenet"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000034258","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T02:08:00Z","timestamp":1746324480000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000034258"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,28]]},"references-count":16,"journal-issue":{"issue":"30","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000034258","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7,28]]}}}